AlphaTON Capital Corp (ATON)
NCM · ADR · CUSIP G7185A102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ATON and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
G7185A102
Market Cap
Small Cap
Previous Symbol
PRTG (changed 9/2/2025)
Previous Name
Portage Biotech Inc.
Business: AlphaTON Capital Corp. is a clinical stage immuno-oncology company focused on overcoming immune resistance. The Company sources, nurture, and develop thecreation of early-to mid-stage, first-and best-in-class therapies for a variety of cancers, by providing funding, implementingviable, cost effectiveproduct development strategies, clinical counsel/trial design, shared services, financial and project management to enable efficient, turnkey execution of commercially informed development plans.

Company Contact

CEO
Alexander Pickett
CFO
Andrea Park
Investor Relations
Chuck Padala, LifeSci Advisors · chuck@lifesciadvisors.com
SEC EDGAR Filings
View filings »